Molecular defects in the ABCA1 pathway affect platelet function - PubMed (original) (raw)
Review
Molecular defects in the ABCA1 pathway affect platelet function
Gerd Schmitz et al. Pathophysiol Haemost Thromb. 2006.
Abstract
Platelet function is sensitive to alterations in cholesterol metabolism, and hypercholesterolemia is associated with enhanced platelet reagibility. Atherogenic low-density lipoproteins (LDL), in particular oxidized LDL, activate src-kinase-family-dependent signalling. In contrast, antiatherogenic high-density lipoproteins(HDL) inhibit platelet aggregation and target the phosphatidylinositol phospholipase C (PI-PLC) pathway. Sphingosine 1-phosphate is a major HDL component and may be crucial for downstream reactions of collagen-induced glycoprotein VI signalling and phosphoinositide 3-kinase. The ATP-binding cassette transporter A1 (ABCA1) regulates cell membrane phospholipid and cholesterol homeostasis and their release to lipid-poor apolipoprotein AI to generate prebeta-HDL precursor particles. ABCA1 also interacts with modulators of vesicular trafficking and number and impaired release of dense bodies from platelets. The ABCA1-NH2-terminus-associated Syntaxin-13, a SNARE complex protein, interacts with syntaxin 13-interacting protein (pallidin) whose deficiency leads to impaired platelet granule release from the dense granule Adapter Protein-3 (AP-3)-related pathway. Interestingly, the cholesterol transporter ABCG1 in addition to ABCA1 is another constituent of the AP-3 pathway, and disorders of lysosome-related organelles such as the Hermansky-Pudlack syndrome complex, Chediak-Higashi syndrome and the ceroid lipofuscinoses provide new opportunities to understand AP-3 pathway-related disorders and the irrelation to membrane phospholipid processing. ABCA1 mutations are involved in dysregulated vesicular trafficking from the trans golgi compartment to the plasma membrane, and ABCA1 R1925Q was shown to contribute to Scott syndrome, a phospholipid-processing disorder of missing surface exposure of phosphatidlyserine. The P2Y12 receptor triggers dense granule secretion by downstream effectors including the G-protein-coupled inward rectifier K+ channel-4 (GIRK-4), and we found the sister geneGIRK-3 associated with the ABCA1 protein in macrophages. It is concluded that the presence of ABCA1 and ABCG1 in the AP-3 pathway will have major impact for membrane phospholipid processing and HDL metabolism and their relation to disorders of lysosome-related organelles.
Similar articles
- Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease).
Nofer JR, Herminghaus G, Brodde M, Morgenstern E, Rust S, Engel T, Seedorf U, Assmann G, Bluethmann H, Kehrel BE. Nofer JR, et al. J Biol Chem. 2004 Aug 6;279(32):34032-7. doi: 10.1074/jbc.M405174200. Epub 2004 May 25. J Biol Chem. 2004. PMID: 15163665 - HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM, Kim MJ, Hou L, Le Goff W, Chapman MJ, Van Eck M, Curtiss LK, Burnett JR, Cartland SP, Quinn CM, Kockx M, Kontush A, Rye KA, Kritharides L, Jessup W. Du XM, et al. Circ Res. 2015 Mar 27;116(7):1133-42. doi: 10.1161/CIRCRESAHA.116.305485. Epub 2015 Jan 14. Circ Res. 2015. PMID: 25589556 - ABCA1: regulation, trafficking and association with heteromeric proteins.
Schmitz G, Buechler C. Schmitz G, et al. Ann Med. 2002;34(5):334-47. doi: 10.1080/078538902320772098. Ann Med. 2002. PMID: 12452478 Review. - ABCA1: at the nexus of cholesterol, HDL and atherosclerosis.
Attie AD. Attie AD. Trends Biochem Sci. 2007 Apr;32(4):172-9. doi: 10.1016/j.tibs.2007.02.001. Epub 2007 Feb 26. Trends Biochem Sci. 2007. PMID: 17324574 Review. - The expression of ATP-binding cassette transporters in hypertensive patients.
Xu M, Zhou H, Gu Q, Li C. Xu M, et al. Hypertens Res. 2009 Jun;32(6):455-61. doi: 10.1038/hr.2009.46. Epub 2009 Apr 24. Hypertens Res. 2009. PMID: 19390536
Cited by
- The Role of ABC Transporters in Lipid Metabolism and the Comorbid Course of Chronic Obstructive Pulmonary Disease and Atherosclerosis.
Kotlyarov S, Kotlyarova A. Kotlyarov S, et al. Int J Mol Sci. 2021 Jun 23;22(13):6711. doi: 10.3390/ijms22136711. Int J Mol Sci. 2021. PMID: 34201488 Free PMC article. Review. - Exclusion of ABCA-1 as a candidate gene for canine Scott syndrome.
Brooks MB, Catalfamo JL, Etter K, Brisbin A, Bustamante CD. Brooks MB, et al. J Thromb Haemost. 2008 Sep;6(9):1608-10. doi: 10.1111/j.1538-7836.2008.03068.x. J Thromb Haemost. 2008. PMID: 18844827 Free PMC article. No abstract available. - Pallidin protein in neurodevelopment and its relation to the pathogenesis of schizophrenia.
Shi Q, Li C, Li K, Liu Q. Shi Q, et al. Mol Med Rep. 2017 Feb;15(2):665-672. doi: 10.3892/mmr.2016.6064. Epub 2016 Dec 21. Mol Med Rep. 2017. PMID: 28035416 Free PMC article. - A genome-wide linkage scan in German shepherd dogs localizes canine platelet procoagulant deficiency (Scott syndrome) to canine chromosome 27.
Brooks M, Etter K, Catalfamo J, Brisbin A, Bustamante C, Mezey J. Brooks M, et al. Gene. 2010 Jan 15;450(1-2):70-5. doi: 10.1016/j.gene.2009.09.016. Gene. 2010. PMID: 19854246 Free PMC article. - ABCC4 impacts megakaryopoiesis and protects megakaryocytes against 6-mercaptopurine induced cytotoxicity.
Ranjit S, Wang Y, Zhu J, Cheepala SB, Schuetz EG, Cho WJ, Xu B, Robinson CG, Wu G, Naren AP, Schuetz JD. Ranjit S, et al. Drug Resist Updat. 2024 Jan;72:101017. doi: 10.1016/j.drup.2023.101017. Epub 2023 Nov 8. Drug Resist Updat. 2024. PMID: 37988981 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous